Sequencing of Cutaneous Squamous Cell Carcinoma Primary Tumors and Patient-Matched Metastases Reveals <i>ALK</i> as a Potential Driver in Metastases and Low Mutational Concordance in Immunocompromised Patients.

Lobl, Marissa B; Clarey, Dillon D; Higgins, Shauna; Sutton, Adam; Wysong, Ashley

Sequencing of Cutaneous Squamous Cell Carcinoma Primary Tumors and Patient-Matched Metastases Reveals ALK as a Potential Driver in Metastases and Low Mutational Concordance in Immunocompromised Patients.

Lobl, Marissa B; Clarey, Dillon D; Higgins, Shauna; Sutton, Adam; Wysong, Ashley.

Afiliación

Lobl MB; Department of Dermatology, College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Clarey DD; Department of Dermatology, College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Higgins S; Department of Dermatology, Keck School of Medicine of University of Southern California, University of Southern California, Los Angeles, California, USA.
Sutton A; Department of Dermatology, College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Wysong A; The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, USA.

JID Innov ; 2(4): 100122, 2022 Jul.

Article en En | MEDLINE | ID: mdl-35620707

Palabras clave

ERK, extracellular signalregulated kinase; SCC, squamous cell carcinoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: JID Innov Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google